We are delighted to announce that CCLG partner The Little Princess Trust has been accepted into membership of the Association of Medical Research Charities (AMRC).
The AMRC is a membership organisation dedicated to supporting medical research charities in saving and improving lives through research and innovation. To be accepted into membership, charities must demonstrate they fund the best quality research through robust funding processes and compliance with AMRC standards.
The Little Princess Trust funds research in partnership with the Children’s Cancer and Leukaemia Group (CCLG), who have been a member of AMRC since 2017. CCLG provides guidance and support to the Little Princess Trust and manages their research funding programme, working closely in partnership at all stages of the process. This sharing of expertise and resources has meant that the Little Princess Trust’s research programme has been compliant with AMRC since it began funding research, as well as minimising duplication of resources, ensuring that more money can be invested directly into world-class childhood cancer research.
Phil Brace, Chief Executive of The Little Princess Trust, said: “We are thrilled to have achieved AMRC membership. Since we began funding research, it has been one of our key aims to ensure that we prioritise the best quality, innovative research which will lead to the biggest impact for children.
This accolade reflects our ambitions in this area, but there’s much more to do - we promise we won’t stop funding new treatments and clinical trials until we reach our goal of ensuring that no child dies from cancer. It is an ambitious target but we believe that with the continued backing from our amazing supporters our aim is achievable.”
Ashley Gamble, Chief Executive of CCLG, said: “It has been a privilege working with The Little Princess Trust to develop and support their research funding programme. Achieving AMRC membership is testament to their dedication to ensure they support the best research, and the best researchers, to improve outcomes for children with cancer. Supporting them to become one of the most significant funders of childhood cancer research in the UK has been a personal highlight and I look forward to continuing to work with them over the coming years.”
Since 2016, The Little Princess Trust has invested more than £15million across more than 80 projects, covering a wide range of children’s cancers. You can find out more about the projects that have been funded at www.cclg.org.uk/our-research-projects/LPT. This year, the Trust published its first formal research strategy, outlining its ambitious goals to encourage and champion innovation, and to ensure their research funding is driven by improving patient outcomes, identifying unmet need, and answering unanswered questions; bringing better treatments to children and young people sooner.